Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 50 | 2024 | 5130 | 3.290 |
Why?
|
| Lithium | 7 | 2020 | 600 | 0.940 |
Why?
|
| Affect | 9 | 2024 | 1494 | 0.810 |
Why?
|
| Lithium Compounds | 6 | 2018 | 226 | 0.760 |
Why?
|
| Anxiety Disorders | 9 | 2024 | 2745 | 0.740 |
Why?
|
| Benzodiazepines | 2 | 2015 | 1137 | 0.600 |
Why?
|
| Suicide | 6 | 2018 | 1606 | 0.560 |
Why?
|
| Personality Assessment | 1 | 2018 | 646 | 0.540 |
Why?
|
| Anxiety | 3 | 2024 | 4670 | 0.530 |
Why?
|
| Suicidal Ideation | 4 | 2019 | 1467 | 0.470 |
Why?
|
| Social Support | 1 | 2024 | 2192 | 0.460 |
Why?
|
| Suicide, Attempted | 7 | 2019 | 1413 | 0.430 |
Why?
|
| Antipsychotic Agents | 9 | 2018 | 3078 | 0.430 |
Why?
|
| Saliva | 3 | 2019 | 853 | 0.410 |
Why?
|
| Executive Function | 8 | 2018 | 1396 | 0.400 |
Why?
|
| Antidepressive Agents | 5 | 2018 | 2912 | 0.370 |
Why?
|
| Antimanic Agents | 4 | 2018 | 524 | 0.360 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4526 | 0.310 |
Why?
|
| Disability Evaluation | 1 | 2016 | 1829 | 0.300 |
Why?
|
| Severity of Illness Index | 7 | 2024 | 15925 | 0.270 |
Why?
|
| Outpatients | 1 | 2015 | 1600 | 0.270 |
Why?
|
| Bupropion | 2 | 2017 | 303 | 0.240 |
Why?
|
| Hydrocortisone | 2 | 2018 | 1840 | 0.240 |
Why?
|
| Cognition | 8 | 2020 | 7059 | 0.210 |
Why?
|
| Depression | 3 | 2018 | 8234 | 0.200 |
Why?
|
| Behavioral Symptoms | 1 | 2024 | 188 | 0.200 |
Why?
|
| Adult | 45 | 2024 | 223317 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2018 | 6023 | 0.200 |
Why?
|
| Longitudinal Studies | 10 | 2023 | 14766 | 0.190 |
Why?
|
| Personality | 3 | 2018 | 559 | 0.190 |
Why?
|
| Life Change Events | 2 | 2024 | 956 | 0.180 |
Why?
|
| Quality of Life | 5 | 2018 | 13485 | 0.180 |
Why?
|
| Substance-Related Disorders | 4 | 2018 | 4422 | 0.160 |
Why?
|
| Pituitary-Adrenal System | 3 | 2018 | 555 | 0.160 |
Why?
|
| Comparative Effectiveness Research | 4 | 2018 | 713 | 0.160 |
Why?
|
| Psychotic Disorders | 5 | 2017 | 3275 | 0.150 |
Why?
|
| Male | 45 | 2024 | 364203 | 0.150 |
Why?
|
| Employment | 2 | 2016 | 1110 | 0.150 |
Why?
|
| Female | 47 | 2024 | 396660 | 0.150 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2018 | 703 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2018 | 187 | 0.140 |
Why?
|
| Dibenzothiazepines | 2 | 2014 | 102 | 0.140 |
Why?
|
| Polypharmacy | 1 | 2019 | 307 | 0.130 |
Why?
|
| Age of Onset | 3 | 2018 | 3344 | 0.130 |
Why?
|
| Binge-Eating Disorder | 1 | 2018 | 156 | 0.130 |
Why?
|
| Cognitive Reserve | 1 | 2017 | 92 | 0.130 |
Why?
|
| Humans | 55 | 2024 | 767040 | 0.130 |
Why?
|
| Serotonin | 1 | 2001 | 1045 | 0.130 |
Why?
|
| Valproic Acid | 1 | 2018 | 444 | 0.130 |
Why?
|
| Receptors, GABA | 1 | 2018 | 312 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2021 | 65295 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 267 | 0.120 |
Why?
|
| Neuropsychological Tests | 10 | 2020 | 7121 | 0.120 |
Why?
|
| Young Adult | 12 | 2024 | 59980 | 0.120 |
Why?
|
| Circadian Rhythm | 4 | 2019 | 2591 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 643 | 0.120 |
Why?
|
| Comorbidity | 6 | 2019 | 10582 | 0.120 |
Why?
|
| Photic Stimulation | 2 | 2019 | 1989 | 0.120 |
Why?
|
| Polysomnography | 2 | 2019 | 1868 | 0.120 |
Why?
|
| Attention | 2 | 2015 | 2413 | 0.120 |
Why?
|
| Sleep Stages | 1 | 2018 | 705 | 0.110 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2012 | 225 | 0.110 |
Why?
|
| Middle Aged | 32 | 2019 | 223233 | 0.110 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 491 | 0.110 |
Why?
|
| Memory | 2 | 2014 | 2192 | 0.110 |
Why?
|
| Psychological Tests | 1 | 2015 | 642 | 0.110 |
Why?
|
| Melatonin | 1 | 2019 | 670 | 0.110 |
Why?
|
| Cost of Illness | 2 | 2021 | 1951 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 682 | 0.110 |
Why?
|
| Internationality | 1 | 2018 | 1006 | 0.100 |
Why?
|
| DNA Repeat Expansion | 1 | 2013 | 74 | 0.100 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2013 | 149 | 0.100 |
Why?
|
| Risk Factors | 12 | 2024 | 74886 | 0.100 |
Why?
|
| Arousal | 1 | 2018 | 1174 | 0.100 |
Why?
|
| Intelligence | 1 | 2017 | 925 | 0.100 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 571 | 0.090 |
Why?
|
| Motor Skills | 1 | 2014 | 521 | 0.090 |
Why?
|
| Self Report | 3 | 2019 | 3773 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2018 | 1345 | 0.090 |
Why?
|
| Emotions | 2 | 2013 | 2760 | 0.090 |
Why?
|
| Cognition Disorders | 5 | 2018 | 3968 | 0.090 |
Why?
|
| Child | 8 | 2024 | 80771 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 771 | 0.080 |
Why?
|
| Adolescent | 12 | 2024 | 89046 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 1 | 2015 | 836 | 0.080 |
Why?
|
| Family Health | 1 | 2013 | 1254 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2018 | 4167 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2019 | 2191 | 0.070 |
Why?
|
| Case-Control Studies | 8 | 2017 | 22254 | 0.070 |
Why?
|
| Family | 1 | 2017 | 3210 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 18063 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2012 | 1399 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2015 | 1653 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2012 | 1193 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2006 | 362 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2011 | 1129 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2006 | 619 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2647 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 26325 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 661 | 0.050 |
Why?
|
| Prevalence | 5 | 2018 | 15851 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2018 | 24299 | 0.050 |
Why?
|
| Depressive Disorder | 2 | 2006 | 3721 | 0.050 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 642 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2014 | 1712 | 0.050 |
Why?
|
| Fenfluramine | 1 | 2001 | 58 | 0.050 |
Why?
|
| Choice Behavior | 2 | 2017 | 848 | 0.040 |
Why?
|
| Lipids | 1 | 2012 | 3322 | 0.040 |
Why?
|
| Raphe Nuclei | 1 | 2001 | 104 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2017 | 1987 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 54886 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2018 | 89 | 0.040 |
Why?
|
| Sex Factors | 3 | 2018 | 10622 | 0.040 |
Why?
|
| Brain | 2 | 2006 | 27163 | 0.040 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 97 | 0.040 |
Why?
|
| Proteins | 1 | 2013 | 6001 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2001 | 898 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2016 | 41718 | 0.040 |
Why?
|
| Smoking | 1 | 2014 | 9081 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 2017 | 135 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2018 | 342 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 655 | 0.030 |
Why?
|
| Tablets | 1 | 2017 | 149 | 0.030 |
Why?
|
| Language Tests | 1 | 2017 | 191 | 0.030 |
Why?
|
| Depressive Disorder, Major | 2 | 2011 | 4813 | 0.030 |
Why?
|
| Exercise | 1 | 2013 | 5954 | 0.030 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 197 | 0.030 |
Why?
|
| Aftercare | 1 | 2002 | 915 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2017 | 236 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 2018 | 405 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2017 | 196 | 0.030 |
Why?
|
| Aggression | 1 | 2001 | 748 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5886 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2017 | 504 | 0.030 |
Why?
|
| Perception | 2 | 2013 | 1205 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2013 | 2245 | 0.030 |
Why?
|
| Atrophy | 1 | 2001 | 1631 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8729 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2013 | 6977 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2018 | 935 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 2017 | 418 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 16036 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2017 | 810 | 0.030 |
Why?
|
| Australia | 1 | 2017 | 1263 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 965 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1326 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 996 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2015 | 1018 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1188 | 0.030 |
Why?
|
| Trail Making Test | 1 | 2012 | 57 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2018 | 963 | 0.030 |
Why?
|
| Logistic Models | 2 | 2019 | 13284 | 0.030 |
Why?
|
| Stroop Test | 1 | 2012 | 72 | 0.030 |
Why?
|
| Fatty Acid Desaturases | 1 | 2012 | 102 | 0.020 |
Why?
|
| alpha-Linolenic Acid | 1 | 2012 | 144 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2012 | 300 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 771 | 0.020 |
Why?
|
| Cholesterol | 1 | 2001 | 2905 | 0.020 |
Why?
|
| Decision Making | 2 | 2016 | 3951 | 0.020 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 138 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2105 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3621 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 18989 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2001 | 2224 | 0.020 |
Why?
|
| Educational Status | 1 | 2017 | 2511 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2353 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20169 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15645 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15424 | 0.020 |
Why?
|
| Time Factors | 3 | 2016 | 40154 | 0.020 |
Why?
|
| Motivation | 1 | 2018 | 2021 | 0.020 |
Why?
|
| Body Weight | 1 | 2018 | 4627 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29963 | 0.020 |
Why?
|
| Facial Expression | 1 | 2011 | 515 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 2086 | 0.020 |
Why?
|
| Alcoholism | 1 | 2018 | 1980 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5875 | 0.020 |
Why?
|
| Aged | 6 | 2016 | 171319 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6893 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2018 | 3207 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 3060 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12536 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 13646 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18401 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6215 | 0.020 |
Why?
|
| Child Abuse | 1 | 2014 | 1090 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 2605 | 0.020 |
Why?
|
| Face | 1 | 2011 | 1029 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2018 | 6260 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2013 | 1089 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3212 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14672 | 0.010 |
Why?
|
| Puberty | 1 | 2006 | 501 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4560 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9362 | 0.010 |
Why?
|
| Sleep | 1 | 2019 | 4816 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5098 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12069 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10393 | 0.010 |
Why?
|
| Seizures | 1 | 2014 | 2996 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6513 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 13048 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39317 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2013 | 3591 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16718 | 0.010 |
Why?
|
| Diet | 1 | 2018 | 8089 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9606 | 0.010 |
Why?
|
| Estradiol | 1 | 2006 | 1951 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12790 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 6282 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2017 | 81659 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6597 | 0.010 |
Why?
|
| Testosterone | 1 | 2006 | 2490 | 0.010 |
Why?
|
| Asthma | 1 | 2014 | 6268 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 81912 | 0.010 |
Why?
|
| United States | 1 | 2018 | 72971 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10092 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168965 | 0.000 |
Why?
|
| Neoplasms | 1 | 2014 | 22350 | 0.000 |
Why?
|
| Hospitalization | 1 | 2002 | 10815 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36582 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_